E
Everpace
Interactive pharmaceutical information service with slick sliders, and 'on' and 'off' clickable categories with detailed product information
About Everpace
Micro Inventive Physiology is a high technology enterprise specializing in the development, production, and marketing of cutting-edge medical devices in the field of electrophysiology intervention and palliative care. The company is dedicated to providing globally competitive solutions for precise diagnostics and palliative care interventions.
Founded on August 31, 2010, in the Medical Valley Park of the International Medical Park in Shanghai, Micro Inventive Physiology has established itself as a leader in medical technology innovation. The company collaborates with Stereotaxis to advance the application of electrophysiology robots in China.
Micro Inventive Physiology serves healthcare providers and medical institutions that require advanced electrophysiology and palliative care solutions. The company operates in the medical device market, focusing on precision intervention technologies.
The business model revolves around the development and commercialization of innovative medical devices, generating revenue through the sale of these products to hospitals and clinics. Key products include the OptimAblate heart radio frequency machine, OptimAblate injection pump, Columbus heart electrophysiology stimulator, and FlashPoint kidney arteries melting system, all of which have received CE certification.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2018
- Headquarters
- Reno, United States
- Open positions
- None listed
- Dealroom signal
- 55.9/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Surgery, Hard Tech, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Aug 2020 | $41M | $165M | Grand Flight Investment · Pudong Science and Technology Innovation · E-Fund · CITIC Limited | ↗ |
Growth signals
Latest recorded traffic for Everpace is 1.5K monthly website visits, down 81.3% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later4 investors entered at this stage
Grand Flight Investment- PIPudong Science and Technology Innovation
E-Fund- CLCITIC Limited
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Everpace on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Everpace’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.